Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Market Videos
Currencies
International
Treasury & Bonds
Search InvestCenter
Recent Quotes
My Watchlist
Indicators
(NQ: )
N/A   UNCHANGED
Last Price  /  Updated:   /  Add to My Watchlist      
View: Quote News
All news about
 
< Previous 1 2 3 Next >
Panacos Announces Voluntary Decision to Delist Common Stock from Nasdaq and Terminate SEC Registration of Common Stock
February 27, 2009
from Business Wire News Releases
Panacos Pharmaceuticals (PANC) Hires Oppenheimer & Co. to Review Strategic Alternatives; Reduces Workforce
February 23, 2009
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=4428060 for the full story. Read More
from StreetInsider.com News Articles
Panacos Provides Corporate and Strategic Update
February 23, 2009
from Business Wire News Releases
Panacos Announces Additional Personnel Departures
February 11, 2009
from Business Wire News Releases
Myriad Pharmaceuticals Acquires Novel HIV Drug, Bevirimat
January 21, 2009
Bevirimat, a First-in-Class Maturation Inhibitor, Represents a New Class of HIV Drugs Read More
from Marketwired News Releases
Panacos Announces Sale of Bevirimat
January 21, 2009
from Business Wire News Releases
Panacos Provides Update on Corporate Strategy
December 10, 2008
from Business Wire News Releases
Panacos Announces Repayment of Hercules Loan
November 22, 2008
from Business Wire News Releases
Panacos Pharmaceuticals (PANC) Reports Q3 Loss of $0.15, Beats by 5c
November 05, 2008
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=4129718 for the full story. Read More
from StreetInsider.com News Articles
Panacos Reports Third Quarter 2008 Financial Results
November 05, 2008
from Business Wire News Releases
Panacos Announces Preliminary Results of Bevirimat Study 204
October 27, 2008
Results confirm bevirimat tablet formulation dosed twice daily achieves target plasma levels Read More
from Business Wire News Releases
Panacos to Report Third Quarter Results and Provide Development Update
October 27, 2008
from Business Wire News Releases
Panacos Presents Phase 2b Bevirimat Data at the 48th Annual Interscience Conference on Antimicrobial Agents and Chemotherapy
October 26, 2008
from Business Wire News Releases
Panacos' Study 114 Supports the Company's New Tablet Formulation of Bevirimat
October 07, 2008
-- 100mg Tablet Formulation will Move Forward in Development -- Read More
from Business Wire News Releases
Panacos to Present at Oppenheimer Small and Mid Cap Clinical and Regulatory Conference
July 31, 2008
from Business Wire News Releases
Panacos Pharmaceuticals, Inc. (PANC) Reports Q3 In-Line
July 30, 2008
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=3861996 for the full story. Read More
from StreetInsider.com News Articles
Panacos Reports Second Quarter 2008 Financial Results
July 30, 2008
from Business Wire News Releases
Panacos Announces Stock Listing Transfer to The Nasdaq Capital Market
July 29, 2008
from Business Wire News Releases
Panacos to Present Clinical Data on Bevirimat at the 48th Annual Interscience Conference on Antimicrobial Agents and Chemotherapy
July 28, 2008
from Business Wire News Releases
Panacos to Report Second Quarter Results and Provide Development Update
July 23, 2008
from Business Wire News Releases
Pre-Open Movers 6/18: Lindsay Corp (LNN) Lower After Results, Fifth Third (FITB) Sinks on Capital Raise/Div Cut/Revised Capital Ratio
June 18, 2008
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=3753841 for the full story. Read More
from StreetInsider.com News Articles
Panacos Announces Results of Bevirimat Prospective Study, which Confirm Patient Response Predictors
June 17, 2008
Completed Phase 2b Extension Study Determines Likely Phase 3 Patient Profile Read More
from Business Wire News Releases
Panacos Presents Bevirimat Patient Response Predictors at the International HIV Drug Resistance Workshop
June 11, 2008
from Business Wire News Releases
Panacos to Webcast its R&D Day on Wednesday, June 18th
June 11, 2008
from Business Wire News Releases
Semi-Annual Changes to the NASDAQ Biotechnology Index
May 09, 2008
from GlobeNewswire News Releases
Semi-Annual Changes to the NASDAQ Biotechnology Index
May 09, 2008
from GlobeNewswire News Releases
Panacos to Present at Deutsche Bank Health Care Conference
May 01, 2008
from Business Wire News Releases
Panacos Pharmaceuticals (PANC) Reports Q1 Loss of $0.16, Tops Street By 3c
April 24, 2008
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=3575283 for the full story. Read More
from StreetInsider.com News Articles
Panacos Reports First Quarter 2008 Financial Results
April 24, 2008
from Business Wire News Releases
Panacos to Report First Quarter Results for 2008
April 17, 2008
from Business Wire News Releases
< Previous 1 2 3 Next >
Stock Market XML and JSON Data API provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays. Stock Market Holiday List
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Press Release Service provided by PRConnect.
Stock quotes supplied by Telekurs USA
Postage Rates Bots go here